Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 21:14:1457-1468.
doi: 10.2147/IJGM.S274568. eCollection 2021.

Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Affiliations
Review

Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Sarah Patel et al. Int J Gen Med. .

Abstract

Irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) are two common disorders of gut-brain interaction. Affected patients often first present to their primary care providers seeking care for symptoms of constipation, abdominal pain, and bloating, which have a significant impact on their health-related quality of life. These patients often require extensive counseling and reassurance, and knowledge of reliable diagnostic criteria and treatment options is imperative to managing their conditions. Family medicine practitioners, including nurse practitioners and physician assistants, are uniquely qualified to provide a diagnosis and safe, effective management of these disorders. This article reviews the latest evidence and provides practical advice related to diagnosis and management of IBS-C and CIC.

Keywords: advanced practice providers; chronic idiopathic constipation; constipation; irritable bowel syndrome; nurse practitioners; physician assistants.

PubMed Disclaimer

Conflict of interest statement

Financial arrangements of the authors with companies whose products may be related to the present report are listed as follows: Sarah Patel is a consultant for Allergan plc. Elayne DeSimone is a consultant for Allergan plc. Bethany Doerfler has no conflicts to disclose. Katerine Boutros is an employee of AbbVie Inc. Samson Ng is a former employee of AbbVie Inc. and owned stock/stock options at the time of employment. Machelle Manuel is a former employee of Ironwood Pharmaceuticals, Inc., and owned stock/stock options at the time of employment. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Disorders of gut–brain interaction exist on a continuum.
Figure 2
Figure 2
Diagnosing IBS-C and CIC.

Similar articles

Cited by

References

    1. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407.e5. doi:10.1053/j.gastro.2016.02.031 - DOI - PubMed
    1. Heidelbaugh JJ, Stelwagon M, Miller SA, Shea EP, Chey WD. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. Am J Gastroenterol. 2015;110(4):580–587. doi:10.1038/ajg.2015.67 - DOI - PMC - PubMed
    1. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262–1279. doi:10.1053/j.gastro.2016.02.032 - DOI - PubMed
    1. Halder SLS, Locke GR, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133(3):799–807. doi:10.1053/j.gastro.2007.06.010 - DOI - PubMed
    1. Harris LA, Horn J, Kissous-Hunt M, Magnus L, Quigley EMM. The better understanding and recognition of the disconnects, experiences, and needs of patients with chronic idiopathic constipation (BURDEN-CIC) study: results of an online questionnaire. Adv Ther. 2017;34(12):2661–2673. doi:10.1007/s12325-017-0633-5 - DOI - PMC - PubMed

LinkOut - more resources